COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
Allergy - 77(2022), 3 vom: 01. März, Seite 1048-1051 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Banerji, Aleena [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
15H5577CQD |
|---|
| Anmerkungen: |
Date Completed 02.03.2022 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/all.15178 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333167627 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333167627 | ||
| 003 | DE-627 | ||
| 005 | 20231225221106.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/all.15178 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1110.xml |
| 035 | |a (DE-627)NLM333167627 | ||
| 035 | |a (NLM)34779000 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Banerji, Aleena |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.03.2022 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID | |
| 650 | 4 | |a PEG | |
| 650 | 4 | |a SARS-CoV | |
| 650 | 4 | |a docetaxel | |
| 650 | 4 | |a drug allergy | |
| 650 | 4 | |a paclitaxel | |
| 650 | 4 | |a vaccine allergy | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Docetaxel |2 NLM | |
| 650 | 7 | |a 15H5577CQD |2 NLM | |
| 650 | 7 | |a Paclitaxel |2 NLM | |
| 650 | 7 | |a P88XT4IS4D |2 NLM | |
| 700 | 1 | |a Wolfson, Anna R |e verfasserin |4 aut | |
| 700 | 1 | |a Robinson, Lacey B |e verfasserin |4 aut | |
| 700 | 1 | |a McMahon, Aubree E |e verfasserin |4 aut | |
| 700 | 1 | |a Cogan, Amelia S |e verfasserin |4 aut | |
| 700 | 1 | |a Saff, Rebecca R |e verfasserin |4 aut | |
| 700 | 1 | |a Blumenthal, Kimberly G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Allergy |d 1980 |g 77(2022), 3 vom: 01. März, Seite 1048-1051 |w (DE-627)NLM000313874 |x 1398-9995 |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2022 |g number:3 |g day:01 |g month:03 |g pages:1048-1051 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/all.15178 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 77 |j 2022 |e 3 |b 01 |c 03 |h 1048-1051 | ||